Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



In vitro anti-amylase activity of some Indian dietary spices

Hemlata Janardhan Bhosale,Pornima Pandit Gawali,Tukaram Angad Kadam,Pankaj Onkarsingh Baisthakur.




Abstract
Cited by 9 Articles

Pancreatic alpha amylase (PAA) inhibitory activity of cinnamon, cumin, was evaluated in vitro to search new anti-diabetic agents as alternatives to synthetic medicines. Bark of cinnamon, seeds of cumin, fenugreek, nutmeg and fennel, buds of clove were extracted with hot water, methanol, chloroform, benzene and ethyl acetate and 30 extracts were tested for presence of PAA inhibitory activity using qualitative and quantitative methods and their modes of inhibition were determined. Presence of alpha amylase inhibitors were identified in 18 extracts in quantitative assay. Benzene extracts of cinnamon, clove, fenugreek and nutmeg and chloroform extract of cumin showed highest anti-amylase potential with IC50 values ranged between 2.09±0.12 - 2.89±0.079 mg/ml. All these extracts displayed non-competitive mode of inhibition on amylase activity as determined in terms of changes in Vmax and km values. In conclusion, active constituents of these five extracts possess anti-diabetic properties and can be used in management of diabetes mediated complications.

Key words: alpha amylase, spices, inhibition, diabetes, cinnamon






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.